EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparing adolescent glomerular disease clinical outcomes to the clinical outcomes in childhood, young adult, and adult-onset glomerular disease in the CureGN database

Kelly Garrity, Nathaniel Putnam, Elaine S Kamil, Susan Massengill, Myda Khalid, Rachana Srivastava, Jaya Isaacs, Eloise Salmon

Pediatric Nephrology · 2025-06 · 40 (6) · 1949-1958

DOI: 10.1007/s00467-024-06566-4 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pediatric Nephrology, online erschienen am 27.12.2024. Verfasst von Kelly Garrity und 7 weiteren Autor:innen. Beteiligte Einrichtung: Mattel Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Kgarrity@mednet.ucla.edu. Hauptthemen laut MEDLINE: Proteinuria, Glomerulonephritis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Medical University of South Carolina.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is a lack of evidence to suggest that outcomes of adolescent and adult-onset glomerular disease differ. Still, most glomerular disease trials include adults but exclude adolescents.

Methods

We designed a retrospective study using the CureGN database to compare individuals with adolescent-onset glomerular disease relative to individuals with older and younger age at onset. The two main outcomes were sustained proteinuria remission off immunosuppression treatment and composite eGFR decline.

Results

Our data did not show a significant difference in sustained proteinuria remission off treatment or composite eGFR decline between adolescent onset glomerular disease and either childhood (age 5–12), young adult (age 20–29), or adult (age 30–39) onset glomerular disease. Having high-risk APOL1 alleles and hypertension at the time of study enrollment decreased the likelihood of achieving sustained proteinuria remission off treatment. While participants with minimal change disease and IgA nephropathy were similarly likely to achieve sustained proteinuria remission off treatment, participants with focal segmental glomerulosclerosis and membranous nephropathy were less likely to achieve sustained proteinuria remission off treatment compared to participants with minimal change disease. CKD stage, high-risk APOL1 alleles, hypertension stage, and education all significantly impacted the likelihood of progression to the composite eGFR decline outcome.

Conclusions

Approximately 25% of each age cohort reached the composite eGFR decline outcome within 5 years. As more glomerular disease clinical trials become available, we must consider opening these trials to people with childhood and adolescent onset disease since like adults they are at high risk of progressive kidney function decline. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteinuriaGlomerulonephritisHumansAdolescentChildMaleFemaleRetrospective StudiesAdultYoung AdultAge of OnsetGlomerular Filtration RateDisease ProgressionDatabases, FactualChild, PreschoolApolipoprotein L1Treatment OutcomeImmunosuppressive AgentsRemission InductionAge Factors

Stichwörter der Autor:innen

AdolescentCKDCureGNFocal glomerulosclerosisGlomerular diseaseIgA nephroapthyMembranous nephropathyMinimal change disease

Substanzen

Apolipoprotein L1APOL1 protein, humanImmunosuppressive Agents

Autor:innen und Institutionen

  • Mattel Department of Pediatrics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA. Kgarrity@mednet.ucla.edu.
  • Medical Univerity of South Carolina, Charleston, SC, USA. Kgarrity@mednet.ucla.edu.
  • University of Michigan School of Medicine, Ann Arbor, MI, USA.
  • Cedars-Sinai Medical Center, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
  • Levine Children's Hospital, Charlotte, NC, USA.
  • Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA.

Förderung

  • NIDDK NIH HHS
  • Medical University of South Carolina

Zitieren

APA

Garrity, K., Putnam, N., Kamil, E. S., Massengill, S., Khalid, M., Srivastava, R., Isaacs, J., & Salmon, E. (2025). Comparing adolescent glomerular disease clinical outcomes to the clinical outcomes in childhood, young adult, and adult-onset glomerular disease in the CureGN database. Pediatric Nephrology, 40(6), 1949-1958. https://doi.org/10.1007/s00467-024-06566-4

Vancouver

Garrity K, Putnam N, Kamil ES, Massengill S, Khalid M, Srivastava R, et al. Comparing adolescent glomerular disease clinical outcomes to the clinical outcomes in childhood, young adult, and adult-onset glomerular disease in the CureGN database. Pediatric Nephrology. 2025;40(6):1949-1958. doi:10.1007/s00467-024-06566-4

BibTeX
@article{Garrity2025,
  author = {Garrity, Kelly and Putnam, Nathaniel and Kamil, Elaine S and Massengill, Susan and Khalid, Myda and Srivastava, Rachana and Isaacs, Jaya and Salmon, Eloise},
  title = {Comparing adolescent glomerular disease clinical outcomes to the clinical outcomes in childhood, young adult, and adult-onset glomerular disease in the CureGN database},
  journal = {Pediatric Nephrology},
  year = {2025},
  volume = {40},
  number = {6},
  pages = {1949--1958},
  doi = {10.1007/s00467-024-06566-4}
}
Kostenlos starten →